The world currently faces the novel severe acute respiratory syndrome coronavirus 2 pandemic.
Little is known about the effects of a pandemic on non-elective neurosurgical practices, …

The translation of therapeutic interventions to humans with spinal cord injury with the goal of
promoting growth and repair in the central nervous system could, inadvertently, drive …

The anticonvulsant pregabalin promotes neural regeneration in a mouse model of spinal
cord injury (SCI). We have also previously observed that anticonvulsants improve motor …

Background In an attempt to aggregate observations from clinical trials, several meta-analyses
have been published examining the effectiveness of systemic, non-opioid, …

Background: The prevalence of pain among people with a variety of individual neurological
conditions has been estimated. However, information is limited about chronic pain among …

Context/Objective The risk for cardiovascular disease is amplified following spinal cord
injury, but whether risk differs between the sexes remains unknown. Here, we evaluated sex …

The placebo response is a complex construct related to psychobiological effects, as well as
natural history and regression to the mean. Moreover, patient and study design …

Reflecting the first wave COVID-19 pandemic in Central Europe (ie March 16th–April 15th,
2020) the neurosurgical community witnessed a general diminution in the incidence of …

The objective of our study was to determine whether treatment with baclofen is neurologically
safe with respect to exposure during recovery from spinal cord injury. We performed a …

Background Recent observational studies have shown an association between gabapentinoid
anticonvulsants and greater motor recovery after spinal cord injury. There is preclinical …